Intellectual Property India Publishes Patent Application for 'Sirna Compositions And Methods Targeting Alpha-Synuclein Nucleic Acids' Filed by Atalanta Therapeutics, Inc.

MUMBAI, India, April 18 -- Intellectual Property India has published a patent application (202517024910 A) filed by Atalanta Therapeutics, Inc., Boston, on March 20, for 'sirna compositions and methods targeting alpha-synuclein nucleic acids.'

Inventor(s) include Gallant-Behm, Corrie; Hassler, Matthew; Curtis, Daniel; and Da Cruz Godinho, Bruno, Miguel.

The application for the patent was published on April 18, under issue no. 16/2025.

According to the abstract released by the Intellectual Property India: "The instant application is directed to single- or double-stranded interfering RNA molecules (e.g., siRNA) that target an alpha-synuclein (SNCA) gene. The interfering RNA molecules may contain specific patterns of nucleoside modification...